http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012139082-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-182
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-65
filingDate 2011-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2012139082-A
titleOfInvention METHODS FOR PRODUCING CYCLOPROPYLAMIDE DERIVATIVES AND INTERMEDIATE COMPOUNDS RELATED TO THEM
abstract 1. The compound of formula Ia or its pharmaceutically acceptable salt: 2. A method of obtaining a compound according to claim 1, comprising reacting a compound of formula IX; with a base and peroxide; and then the interaction of the resulting mixture with an acidic solution. 3. The method according to claim 2, where the compound of formula IX is obtained by a method comprising reacting a compound of formula VIII: with a metal, a metal cyanide and a catalyst, IX represents Cl, Br or I.4. The method according to claim 3, where the compound of formula VIII is obtained by a method comprising reacting a compound of formula VII: with a mixture of the first base and tricalkylphosphonoacetate; and then reacting the resulting mixture with a second base. 5. The method of claim 4, wherein the compound of formula VII is prepared by a process comprising reacting a compound of formula VI: with a base; and LG is Cl, Br, I, tosylate, brosylate, nosylate, mesylate or triflate. 6. The method of claim 5, wherein the compound of formula VI is prepared by a process comprising reacting a compound of formula V: with a reducing agent and a chiral oxazaborolidine. A method of obtaining a compound of formula Ib or a pharmaceutically acceptable salt thereof: comprising reacting a compound of formula Ia: with (1) an activating agent and (2) a compound of formula IVa or a suitable salt thereof: 8. The method according to claim 7, wherein said activating agent is 1,1'-carbonyldiimidazole. The method of claim 7, wherein the compound of formula IVa or a suitable salt thereof is prepared by a process comprising reacting a compound of formula IIIa: with an acid. The method of claim 9, wherein the compound of formula IIIa is prepared by a process comprising reacting a compound of formula IIa: with cyclobutanone and a reducing agent. A method of obtaining a compound of formula Ic or e�
priorityDate 2010-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18994618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21450380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62406
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46861621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447535447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4215492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410531710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414875796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409908092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419705849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407378349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448844975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426023358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465508613

Total number of triples: 55.